Invoice Caragol, CFO of Mainz BioMed MYNZ, was not too long ago a visitor on Benzinga’s All-Entry.
Mainz BioMed, maker of scientific laboratory exams, is dedicated to saving lives and lowering healthcare prices by early illness detection and prevention. For most cancers and persistent situations, sufferers can now dwell longer, more healthy lives because of advances in diagnostic expertise.
Mr. Caragol shared thrilling data about Mainz Bio’s eAArly DETECT 2 examine set to be accomplished in This autumn 2025.
Watch the total interview right here:
Featured picture by Hans Reniers on Unsplash.
This put up accommodates sponsored content material. This content material is for informational functions solely and never meant to be investing recommendation.
Momentum1.88
Progress–
High quality–
Worth27.47
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
